OC
CGEN icon

Oppenheimer & Co’s Compugen CGEN Stock Holding History

Oppenheimer & Co’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,050
Closed -$30.3K – 1663
2025
Q2 		$30.3K Sell
17,050
-39,552
-70% -$58.7K ﹤0.01% 1589
2025
Q1 		$82.6K Buy
56,602
+1,000
+2% +$1.95K ﹤0.01% 1525
2024
Q4 		$85.1K Buy
55,602
+36,252
+187% +$58.9K ﹤0.01% 1513
2024
Q3 		$35K Buy
19,350
+8,350
+76% +$15.2K ﹤0.01% 1488
2024
Q2 		$18.5K Sell
11,000
-5,000
-31% -$10.4K ﹤0.01% 1422
2024
Q1 		$41.3K Sell
16,000
-5,000
-24% -$11.6K ﹤0.01% 1416
2023
Q4 		$41.6K Sell
21,000
-15,000
-42% -$13.1K ﹤0.01% 1353
2023
Q3 		$33.5K Sell
36,000
-16,000
-31% -$17.6K ﹤0.01% 1353
2023
Q2 		$59.3K Buy
52,000
+15,500
+42% +$13.5K ﹤0.01% 1378
2023
Q1 		$25.6K Hold
36,500
– – ﹤0.01% 1357
2022
Q4 		$26.1K Buy
36,500
+5,000
+16% +$4.36K ﹤0.01% 1328
2022
Q3 		$21K Buy
31,500
+15,000
+91% +$21.2K ﹤0.01% 1344
2022
Q2 		$31K Hold
16,500
– – ﹤0.01% 1377
2022
Q1 		$53K Buy
16,500
+5,000
+43% +$16.9K ﹤0.01% 1434
2021
Q4 		$49K Buy
+11,500
New +$62.2K ﹤0.01% 1467

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Oppenheimer & Co's CGEN Position: Q3 2025 in Review

Oppenheimer & Co sold out of Compugen (CGEN) in Q3 2025, closing a stake of 17,050 shares — an estimated $30.3K sold.

Oppenheimer & Co first reported a position in CGEN in Q4 2021 and held it in 15 quarters. The position peaked at $85.1K in Q4 2024. 69 funds tracked by Wall St. Rank hold CGEN as of Q3 2025.

  • Oppenheimer & Co reported no remaining Compugen position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 17,050 Compugen shares in Q3 2025, an estimated $30.3K.
  • Oppenheimer & Co first reported a position in Compugen in Q4 2021 and held it in 15 quarters.
  • Oppenheimer & Co's Compugen position peaked at $85.1K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Compugen as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.